Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

1.8K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.8K
Regulation of Stroke Volume01:27

Regulation of Stroke Volume

4.8K
The regulation of stroke volume, which is the amount of blood the heart pumps out during each heartbeat, is critical for maintaining a healthy circulatory system. Stroke volume is influenced by three main factors: preload, contractility, and afterload.
Preload refers to the degree of stretch on the heart before it contracts. It's analogous to the stretching of a rubber band; the more it's stretched, the more forcefully it snaps back. This concept is encapsulated in the Frank-Starling law of the...
4.8K
Cardiac Output and Stroke Volume01:11

Cardiac Output and Stroke Volume

4.5K
Cardiac output (CO) is an integral aspect of human physiology, reflecting the heart's efficiency and responsiveness to the body's needs. It represents the volume of blood that the left or right ventricle ejects into the aorta or pulmonary trunk each minute. The CO is calculated by multiplying the heart rate (HR)—the number of heartbeats per minute—by the stroke volume (SV)—the amount of blood pumped out with each heartbeat.
In an average resting adult male, the typical cardiac...
4.5K
Cardiac Output II: Effect of Stroke Volume on Cardiac Output01:22

Cardiac Output II: Effect of Stroke Volume on Cardiac Output

3.2K
Cardiac output (CO), the amount of blood the heart pumps per minute, is a parameter in cardiovascular physiology determined by stroke volume and heart rate. Stroke volume, the amount of blood pushed from one of the ventricles per heartbeat, is influenced by preload, afterload, and contractility.
Preload
Preload refers to the initial elongation of the cardiac myocytes before contraction and is related to the volume of blood filling the heart at the end of diastole, or end-diastolic volume. The...
3.2K
What are Cells?01:07

What are Cells?

197.6K
Cells are the smallest and basic units of life, whether it is a single cell that forms the entire organism, e.g., in a bacterium or trillions of them, e.g., in humans. No matter what organism a cell is a part of, they share specific characteristics.
Basic Characteristics of Cells
A living cell has a plasma membrane, a bilayer of lipids that separates the aqueous solution inside the cell called the cytoplasm from the outside environment.
Furthermore, a living cell possesses genetic information...
197.6K
Concentration Cells02:41

Concentration Cells

25.6K
A concentration cell is a type of a  voltaic cell constructed by connecting two almost identical half-cells, both based on the same half-reaction and using the same electrode, differing only in the concentration of one redox species. A concentration cell's potential, therefore, is determined only by the concentration difference of the particular redox species.
Consider the following voltaic cell:
25.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The 2026 AHA/ASA Guideline Updates to Management of Patients with Acute Ischemic Stroke: A Guide for Radiologists.

AJNR. American journal of neuroradiology·2026
Same author

Anti-Seizure Medications Alter Functional and Effective Connectivity as Measured With Intracranial Electroencephalography.

Brain and behavior·2026
Same author

Impaired cerebral autoregulation in patients with moyamoya disease and moyamoya syndrome: A prospective cross-sectional study.

Clinical neurology and neurosurgery·2026
Same author

Optimization of cortico-cortical spectral response analysis parameters for seizure onset zone localization.

Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology·2026
Same author

Quantitative Investigation of Implant Effect of Intracranial EEG Electrodes on Cortico-Cortical Evoked Potentials<sup></sup>.

Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference·2025
Same author

Characteristics of sleep disturbance in Moyamoya disease.

Sleep medicine·2025

Related Experiment Video

Updated: Jan 22, 2026

An Immunohistopathologic Study to Profile the Folate Receptor Beta Macrophage and Vascular Immune Microenvironment in Giant Cell Arteritis
06:35

An Immunohistopathologic Study to Profile the Folate Receptor Beta Macrophage and Vascular Immune Microenvironment in Giant Cell Arteritis

Published on: February 8, 2019

7.6K

Recurrent Stroke in Giant Cell Arteritis Despite Immunotherapy.

Benjamin C Cox1, Jimmy R Fulgham, James P Klaas

  • 1Department of Neurology, Mayo Clinic, Rochester, MN.

The Neurologist
|June 28, 2019
PubMed
Summary

Giant cell arteritis (GCA) can cause rare but severe strokes, even with steroid treatment. Aggressive immunosuppression is crucial for managing these dangerous cerebrovascular complications.

More Related Videos

Manufacturing Chimeric Antigen Receptor CAR T Cells for Adoptive Immunotherapy
06:51

Manufacturing Chimeric Antigen Receptor CAR T Cells for Adoptive Immunotherapy

Published on: December 17, 2019

15.9K
Bacterial Cell Culture at the Single-cell Level Inside Giant Vesicles
07:33

Bacterial Cell Culture at the Single-cell Level Inside Giant Vesicles

Published on: April 30, 2019

7.5K

Related Experiment Videos

Last Updated: Jan 22, 2026

An Immunohistopathologic Study to Profile the Folate Receptor Beta Macrophage and Vascular Immune Microenvironment in Giant Cell Arteritis
06:35

An Immunohistopathologic Study to Profile the Folate Receptor Beta Macrophage and Vascular Immune Microenvironment in Giant Cell Arteritis

Published on: February 8, 2019

7.6K
Manufacturing Chimeric Antigen Receptor CAR T Cells for Adoptive Immunotherapy
06:51

Manufacturing Chimeric Antigen Receptor CAR T Cells for Adoptive Immunotherapy

Published on: December 17, 2019

15.9K
Bacterial Cell Culture at the Single-cell Level Inside Giant Vesicles
07:33

Bacterial Cell Culture at the Single-cell Level Inside Giant Vesicles

Published on: April 30, 2019

7.5K

Area of Science:

  • Neurology
  • Rheumatology
  • Vascular Medicine

Background:

  • Giant cell arteritis (GCA) is a systemic vasculitis primarily affecting medium and large arteries.
  • Cerebrovascular complications, though rare, represent a significant cause of morbidity and mortality in GCA patients.

Observation:

  • A 59-year-old male with GCA presented with lower extremity vasculitis, followed by multiple strokes despite corticosteroid therapy.
  • Angiography revealed stenosis at the dural entry points of bilateral carotid and vertebral arteries.
  • Disease progression and additional strokes occurred even after initiating cyclophosphamide and later switching to tocilizumab.

Findings:

  • GCA can manifest with cerebrovascular events, particularly affecting vessels at the dura mater's entry point.
  • Corticosteroids alone may be insufficient to prevent stroke progression in some GCA cases.
  • Aggressive immunosuppressive therapy escalation is necessary, but outcomes remain poor in severe cases.

Implications:

  • This case underscores the importance of recognizing and promptly treating cerebrovascular complications in GCA.
  • Early escalation of immunosuppressive therapy may be critical for improving outcomes.
  • The predilection for dural entry vessels highlights a specific vulnerability in GCA-related stroke.